Hypericin as a marker for determination of myocardial viability in a rat model of myocardial infarction

Photochemistry and Photobiology

Volumn 90, Issue 4, 2014, Pages 867-872

  Jiang, Cuihua ^a   Li, Yue ^a   Jiang, Xiao ^a   Yao, Nan ^a   Gao, Meng ^a   Zhang, Xueli ^a   Wang, Junying ^a   Wang, Xiaoning ^a   Sun, Ziping ^b   Zhang, Jian ^a   Ni, Yicheng ^a,b,c  

^a Laboratory of Translational Medicine   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERICIN; PERYLENE; TETRAZOLIUM; TRIPHENYLTETRAZOLIUM;

ANALOGS AND DERIVATIVES; ANIMAL; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; GERMFREE ANIMAL; HEART INFARCTION; HEART MUSCLE; MALE; METABOLISM; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; STAINING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROSCOPY, FLUORESCENCE; MYOCARDIAL INFARCTION; MYOCARDIUM; PERYLENE; RATS; RATS, SPRAGUE-DAWLEY; SPECIFIC PATHOGEN-FREE ORGANISMS; STAINING AND LABELING; TETRAZOLIUM SALTS;

EID: 84903816804     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/php.12247     Document Type: Article

References (37)

1. Marwick, T. H., (1998) The viable myocardium: Epidemiology, detection, and clinical implications. Lancet 351, 815-819.
2. Braunwald, E. K. R., (1982) The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 66, 1146-1149.
3. Rahimtoola, S. H., (1989) The hibernating myocardium. Am. Heart J. 117, 211-221.
4. Fishbein, M. C., J. Y-Rit, U. Lando, K. Kanmatsuse, J. C. Mercier, and, W. Ganz, (1980) The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Circulation 62, 1274-1279.
5. Cianfrocca, C., F. Pelliccia, V. Pasceri, A. Auriti, V. Guido, G. Mercuro, and, M. Santini, (2008) Strain rate analysis and levosimendan improve detection of myocardial viability by dobutamine echocardiography in patients with post-infarction left ventricular dysfunction: A pilot study. J. Am. Soc. Echocardiogr. 21, 1068-1074.
6. Khan, Z. R., A. Syed, L. Noor, S. S. Shah, and, M. Hafizullah, (2012) Quantification of diagnostic accuracy using nitrate enhanced Tc-99m sestamibi gated myocardial SPECT in assessing myocardial viability: Prospective analysis. Asian Cardiovasc. Thorac. Ann. 20, 130.
7. Klumpp, B., M. Fenchel, T. Hoevelborn, U. Helber, A. Scheule, C. Claussen, and, S. Miller, (2006) Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla. Invest. Radiol. 41, 661-667.
8. Arrighi, J. A., and, V. Dilsizian, (2012) Multimodality imaging for assessment of myocardial viability: Nuclear, echocardiography, MR, and CT. Current Cardiol. Rep. 14, 234-243.
9. Zhang, W,., R. E. Law, D. R. Hinton, and, W. T. Couldwell, (1997) Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor. Cancer Lett. 120, 31-38.
10. Miccoli, L., A. Beurdeley-Thomas, G. De Pinieux, F. Sureau, S. Oudard, and, B. Dutrillaux, (1997) Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res. 58, 5777-86.
11. Couldwell, W. T., R. Gopalakrishna, D. R. Hinton, S. He, M. H. Weiss, R. E. Law, M. L. Apuzzo, and, R. E. Law, (1994) Hypericin: A potential antiglioma therapy. Neurosurgery 35, 705-10.
12. Zhang, W,., L. Anker, R. E. Law, D. R. Hinton, R. Gopalakrishna, P. Qian, U. Gundimeda, M. H. Weiss, and, T. William, (1996) Couldwell. Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro. Clin. Cancer Res. 2, 843-846.
13. Chen, B., I. Zupko, and, P. A. de Witte, (2001) Photodynamic therapy with hypericin in a mouse P388 tumor model: Vascular effects determine the efficacy. Int. J. Oncol. 18, 737-742.
14. Zaak, D., A. Karl, R. Knüchel, H. Stepp, A. Hartmann, O. Reich, A. Bachmann, M. Siebels, G. Popken, and, C. Stief, (2005) Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int. 96, 17-222.
15. Kubin, A., P. Meissner, F. Wierrani, U. Burner, A. Bodenteich, A. Pytel, and, N. Schmeller, (2008) Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin. Photochem. Photobiol. 84, 1560-1563.
16. Ni, Y., G. Bormans, F. Chen, A. Verbruggen, and, G. Marchal, (2005) Necrosis avid contrast agents: Functional similarity versus structural diversity. Invest. Radiol. 40, 526-535.
17. Van de Putte, M., H. Wang, F. Chen, P. A. M. de Witte, and, Y. Ni, (2008) Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model. Acad. Radiol. 15, 107-113.
18. van Deputte, M., W. Huaijun, F. Chen, P. A. M. de Witte, and, N. Yicheng, (2008) Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model. Oncol. Rep. 19, 927-932.
19. Ni, Y., D. Huyghe, K. Verbeke, P. A. de Witte, J. Nuyts, L. Mortelmans, F. Chen, G. Marchal, A. M. Verbruggen, and, G. M. Bormans, (2006) First preclinical evaluation of mono-[123 I] iodohypericin as a necrosis-avid tracer agent. Eur. J. Nucl. Med. Mol. I (33), 595-601.
20. Li, J., M. M. Cona, F. Chen, Y. Feng, L. Zhou, J. Yu, J. Nuyts, P. de Witte, J. Zhang, and, U. Himmelreich, (2012) Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models. Theranostics 2, 1010-1019.
21. Van de Putte, M., T. Marysael, H. Fonge, T. Roskams, M. M. Cona, J. Li, G. Bormans, A. Verbruggen, Y. Ni, and, P. A. de Witte, (2012) Radiolabeled iodohypericin as tumor necrosis avid tracer: Diagnostic and therapeutic potential. Int. J. Cancer 131, 129-137.
22. Li, J., M. M. Cona, F. Chen, Y. Feng, L. Zhou, G. Zhang, J. Nuyts, P. de Witte, J. Zhang, and, J. Yu, (2013) Sequential systemic administrations of combretastatin A4 phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts. Theranostics 3, 127-137.
23. Fonge, H., K. Vunckx, H. Wang, Y. Feng, L. Mortelmans, J. Nuyts, G. Bormans, A. Verbruggen, and, Y. Ni, (2008) Non-invasive detection and quantification of acute myocardial infarction in rabbits using MONO-[123I] iodohypericin μSPECT. Eur. Heart J. 29, 260-269.
24. Samsamshariat, S. A., Z. A. Samsamshariat, and, M. R. Movahed, (2005) A novel method for safe and accurate left anterior descending coronary artery ligation for research in rats. Cardiovasc. Revascularization Med. 6, 121-123.
25. Feng, Y., Y. Xie, H. Wang, F. Chen, Y. Ye, L. Jin, G. Marchal, and, Y. Ni, (2009) A modified rabbit model of reperfused myocardial infarction for cardiac MR imaging research. Int. J. Cardiovas. Imaging (formerly Cardiac Imaging) 25, 289-298.
26. Staab, R. J., V. De Paul Lynch, C. Lau-Cam, and, M. Barletta, (1977) Small animal model for myocardial infarction. J. Pharm. Sci. 66, 1483-1485.
27. Choi, S. H., S. S. Lee, S. I. Choi, S. T. Kim, K. H. Lim, C. H. Lim, H. J. Weinmann, and, T. H. Lim, (2001) Occlusive myocardial infarction: Investigation of bis-gadolinium mesoporphyrins-enhanced T1-weighted MR imaging in a cat model1. Radiology 220, 436-440.
28. Higuchi, T., S. G. Nekolla, A. Jankaukas, A. W. Weber, M. C. Huisman, S. Reder, S. I. Ziegler, M. Schwaiger, and, F. M. Bengel, (2007) Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J. Nucl. Med. 48, 288-294.
29. Csonka, C., K. Kupai, G. F. Kocsis, G. Novák, V. Fekete, P. Bencsik, T. Csont, and, P. Ferdinandy, (2010) Measurement of myocardial infarct size in preclinical studies. J. Pharmacol. Toxicol. Methods 61, 163-170.
30. Bohl, S., C. A. Lygate, H. Barnes, D. Medway, L. A. Stork, J. Schulz-Menger, S. Neubauer, and, J. E. Schneider, (2009) Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI. Am. J. Physiol.-Heart Circ. Physiol. 296, H1200-H1208.
31. Basu, S., R. J. Binder, R. Suto, K. M. Anderson, and, P. K. Srivastava, (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Planta Med. 12, 1539-1546.
32. Sauter, B., M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and, N. Bhardwaj, (2000) Consequences of cell death exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-434.
33. Srivastava, P., (2002) Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20, 395-425.
34. van de Putte, M., N. YiCheng, and, P. A. De Witte, (2008) Exploration of the mechanism underlying the tumor necrosis avidity of hypericin. Oncol. Rep. 19, 921-926.
35. Hofmann, B., A. Bogdanov, E. Marecos, W. Ebert, S. W., and, R. Weissleder, (1999) Mechanism of gadophrin-2 accumulation in tumor necrosis. J. Magn. Reson. Imaging 9, 336-341.
36. Vermes I, H. C., S.-N. H, and, R. C, (1995) A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods. 184, 39-51.
37. Song, S., C. Xiong, M. Zhou, W. Lu, Q. Huang, G. Ku, J. Zhao, L. G. Jr. Flores, Y. Ni, and, C. Li, (2011) Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin. J. Nucl. Med. 52, 792-799.